guest ::
| Home > Publications database > RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis. > print |
| Home > Publications database > RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis. > print |
| 001 | 296114 | ||
| 005 | 20251202115945.0 | ||
| 024 | 7 | _ | |a 10.1038/s44319-024-00356-7 |2 doi |
| 024 | 7 | _ | |a pmid:39747668 |2 pmid |
| 024 | 7 | _ | |a 1469-221X |2 ISSN |
| 024 | 7 | _ | |a 1469-3178 |2 ISSN |
| 024 | 7 | _ | |a altmetric:174754625 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2025-00044 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Lam, Wai-Ling Macrina |0 P:(DE-HGF)0 |b 0 |e First author |
| 245 | _ | _ | |a RAGE is a key regulator of ductular reaction-mediated fibrosis during cholestasis. |
| 260 | _ | _ | |a Hoboken, NJ [u.a.] |c 2025 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1739280809_30424 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a DKFZ-ZMBH Alliance / 2025 Feb;26(3):880-907 / #EA:A100#LA:A100# |
| 520 | _ | _ | |a Ductular reaction (DR) is the hallmark of cholestatic diseases manifested in the proliferation of bile ductules lined by biliary epithelial cells (BECs). It is commonly associated with an increased risk of fibrosis and liver failure. The receptor for advanced glycation end products (RAGE) was identified as a critical mediator of DR during chronic injury. Yet, the direct link between RAGE-mediated DR and fibrosis as well as the mode of interaction between BECs and hepatic stellate cells (HSCs) to drive fibrosis remain elusive. Here, we delineate the specific function of RAGE on BECs during DR and its potential association with fibrosis in the context of cholestasis. Employing a biliary lineage tracing cholestatic liver injury mouse model, combined with whole transcriptome sequencing and in vitro analyses, we reveal a role for BEC-specific Rage activity in fostering a pro-fibrotic milieu. RAGE is predominantly expressed in BECs and contributes to DR. Notch ligand Jagged1 is secreted from activated BECs in a Rage-dependent manner and signals HSCs in trans, eventually enhancing fibrosis during cholestasis. |
| 536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
| 650 | _ | 7 | |a Biliary Epithelial Cells |2 Other |
| 650 | _ | 7 | |a Chronic Liver Injury |2 Other |
| 650 | _ | 7 | |a Genetically Modified Mice |2 Other |
| 650 | _ | 7 | |a Hepatic Stellate Cells |2 Other |
| 650 | _ | 7 | |a Receptor for Advanced Glycation End Products |2 Other |
| 700 | 1 | _ | |a Gabernet, Gisela |b 1 |
| 700 | 1 | _ | |a Poth, Tanja |b 2 |
| 700 | 1 | _ | |a Sator-Schmitt, Melanie |0 P:(DE-He78)2119821cf3458781f06157c7aeecba8b |b 3 |u dkfz |
| 700 | 1 | _ | |a Oquendo, Morgana Barroso |0 0000-0003-4221-5723 |b 4 |
| 700 | 1 | _ | |a Walter, Bettina |0 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1 |b 5 |u dkfz |
| 700 | 1 | _ | |a Lohr, Sabrina |0 P:(DE-He78)d7efff917864e0e86459893cf0e83a99 |b 6 |u dkfz |
| 700 | 1 | _ | |a De Ponti, Aurora |0 P:(DE-He78)8f8d4ec0bcab2ba838bc964b2e684808 |b 7 |
| 700 | 1 | _ | |a Weiß, Lena |0 P:(DE-He78)59998caf619d8669efab21372b1a2787 |b 8 |
| 700 | 1 | _ | |a Schneider, Martin |0 P:(DE-He78)0d37cc734b95fed555f2244d6fee6320 |b 9 |u dkfz |
| 700 | 1 | _ | |a Helm, Dominic |0 P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1 |b 10 |u dkfz |
| 700 | 1 | _ | |a Müller-Decker, Karin |0 P:(DE-He78)799d978330dff449f8244947929a4518 |b 11 |
| 700 | 1 | _ | |a Schirmacher, Peter |b 12 |
| 700 | 1 | _ | |a Heikenwälder, Mathias |0 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5 |b 13 |u dkfz |
| 700 | 1 | _ | |a Klingmüller, Ursula |0 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6 |b 14 |u dkfz |
| 700 | 1 | _ | |a Schneller, Doris |0 P:(DE-He78)172f117444a06f0aaba2d86c322f7eb2 |b 15 |u dkfz |
| 700 | 1 | _ | |a Geisler, Fabian |b 16 |
| 700 | 1 | _ | |a Nahnsen, Sven |b 17 |
| 700 | 1 | _ | |a Angel, Peter |0 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9 |b 18 |e Last author |u dkfz |
| 773 | _ | _ | |a 10.1038/s44319-024-00356-7 |0 PERI:(DE-600)2025376-X |n 3 |p 880-907 |t EMBO reports |v 26 |y 2025 |x 1469-221X |
| 856 | 4 | _ | |y OpenAccess |u https://inrepo02.dkfz.de/record/296114/files/lam-et-al-2025-rage-is-a-key-regulator-of-ductular-reaction-mediated-fibrosis-during-cholestasis.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://inrepo02.dkfz.de/record/296114/files/lam-et-al-2025-rage-is-a-key-regulator-of-ductular-reaction-mediated-fibrosis-during-cholestasis.pdf?subformat=pdfa |
| 909 | C | O | |o oai:inrepo02.dkfz.de:296114 |p openaire |p open_access |p OpenAPC |p driver |p VDB |p openCost |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 0 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)2119821cf3458781f06157c7aeecba8b |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)417337e7f94f6e1325a168191cbdc4f1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)d7efff917864e0e86459893cf0e83a99 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)8f8d4ec0bcab2ba838bc964b2e684808 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)59998caf619d8669efab21372b1a2787 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 9 |6 P:(DE-He78)0d37cc734b95fed555f2244d6fee6320 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 10 |6 P:(DE-He78)daaed5a5b968028e6e95d273150d5ab1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 11 |6 P:(DE-He78)799d978330dff449f8244947929a4518 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 13 |6 P:(DE-He78)66ed2d4ec9bc11d29b87ac006adf85e5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 14 |6 P:(DE-He78)860df4ab16c373fb28a815dcd81107a6 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 15 |6 P:(DE-He78)172f117444a06f0aaba2d86c322f7eb2 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 18 |6 P:(DE-He78)f4f068e71e0d87bf0ad51e6214ab84e9 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
| 914 | 1 | _ | |y 2025 |
| 915 | p | c | |a APC keys set |0 PC:(DE-HGF)0000 |2 APC |
| 915 | p | c | |a Local Funding |0 PC:(DE-HGF)0001 |2 APC |
| 915 | p | c | |a DFG OA Publikationskosten |0 PC:(DE-HGF)0002 |2 APC |
| 915 | p | c | |a DOAJ Journal |0 PC:(DE-HGF)0003 |2 APC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2023-10-24 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO REP : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2023-10-24 |w ger |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-10-24 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b EMBO REP : 2022 |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2023-10-24 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-10-24 |
| 920 | 2 | _ | |0 I:(DE-He78)A100-20160331 |k A100 |l Signaltransduktion/ Wachstumskontrolle |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)A100-20160331 |k A100 |l Signaltransduktion/ Wachstumskontrolle |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)W120-20160331 |k W120 |l Proteomics |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)W420-20160331 |k W420 |l Gruppe Müller-Decker |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)D440-20160331 |k D440 |l Chronische Entzündung und Krebs |x 3 |
| 920 | 1 | _ | |0 I:(DE-He78)B200-20160331 |k B200 |l B200 Systembiologie der Signaltransduktion |x 4 |
| 920 | 0 | _ | |0 I:(DE-He78)A100-20160331 |k A100 |l Signaltransduktion/ Wachstumskontrolle |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-He78)A100-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W120-20160331 |
| 980 | _ | _ | |a I:(DE-He78)W420-20160331 |
| 980 | _ | _ | |a I:(DE-He78)D440-20160331 |
| 980 | _ | _ | |a I:(DE-He78)B200-20160331 |
| 980 | _ | _ | |a APC |
| 980 | 1 | _ | |a APC |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|